Cooperative Agreement R44MH107065

The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...

This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to advance geriatric palliative care by assessing the feasibility and acceptability of using radio frequency (RF) sensors to capture cardiopulmonary measures in nursing home patients with Alzheimer's disease and related dementias (ADRD). The $451,721 award to Weill Medical College of Cornell University will also develop a machine learning algorithm to autonomously detect and predict respiratory...

This is a Project Grant awarded by the National Science Foundation (NSF) Division of Information and Intelligent Systems under the Computer and Information Science and Engineering program (CFDA 47.070). The $299,708 grant, with a period of performance from August 15, 2023 to July 31, 2027, supports collaborative research to develop AI-driven radio frequency identification (RFID) sensing techniques for smart health monitoring applications. The research aims to create more affordable, comfortable,...

This Project Grant award of $300,000.00 from the National Science Foundation's Division of Information and Intelligent Systems will fund a collaborative research effort led by Florida International University (FIU) to develop AI-driven RFID sensing techniques for smart health applications. The project aims to create more affordable, comfortable, and accessible health monitoring systems by leveraging advances in the Internet of Things and machine learning/AI. The research will focus on addressing...

The National Science Foundation (NSF) awarded a $305,000 STTR Phase I project grant to Sensvita Inc. under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a non-invasive radio frequency sensing technology for home-based monitoring of heart and lung function. The proposed system uses advanced sensing methods to measure critical physiological parameters without the need for skin contact or maintenance, improving the convenience, scalability,...

The Defense Health Agency awarded a $2,463,953 Project Grant to Biosensics LLC for the development of a "Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum." The award, made under the Military Medical Research and Development program (CFDA 12.420), will fund the creation of innovative wearable sensor technologies and cloud-based software solutions to enable remote monitoring and management of frontotemporal dementia and related...

This Project Grant award for $299,997.00 from the National Science Foundation's Computer and Information Science and Engineering Program (CFDA 47.070) supports a collaborative research effort led by Auburn University. The project aims to develop AI-driven radio frequency identification (RFID) sensing techniques to enable more affordable, comfortable, and accessible smart health monitoring systems. The key products and services to be delivered include: Investigating challenges and performance...

This National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Federal Grant Program (CFDA 47.070) award of $1,200,000 provides funding to the University of California, Berkeley from October 1, 2024 to September 30, 2028 to develop innovative sensing technologies that integrate DNA nanotechnology and CMOS electronics for next-generation diagnostics. The key objectives of this project grant are to: (1) develop molecular engineering techniques using DNA origami...

This $427,625 Project Grant awarded by the National Institute on Aging (CFDA 93.866 Aging Research) to the University of Washington aims to develop and optimize two novel blood-based biomarker assays to improve clinical diagnosis and differential diagnosis of Parkinson's disease (PD) and multiple system atrophy (MSA). The key products and services to be delivered under this 2-year grant include: Further development and optimization of a flow cytometry-based assay (APOGEE) to directly quantify...

Federal Cooperative Agreement Award Summary Biosensics LLC received a $5.17 million Cooperative Agreement from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded September 1, 2025, with completion expected August 31, 2029. The award supports development and qualification of digital health monitoring technologies for Progressive Supranuclear Palsy (PSP) and Dementia with Lewy Bodies (DLB), two neurodegenerative conditions lacking FDA-approved treatments and...